American Board of Psychiatry and Neurology (Psychiatry)
American Board of Psychiatry and Neurology (Child and Adolescent Psychiatry)
American Board of Preventive Medicine (Addiction Medicine)
Publications
Crafting Reflections: A Guide to Sharing Your Story in JAACAP. View Abstract
Understanding Involuntary Hospitalization Applications Submitted to an Urban Police Department. View Abstract
Minors and Online Marijuana Accessibility-Navigating the Digital Backdoors. View Abstract
Mitigating the Negative Mental Health Impact of Racism on Black Adolescents-A Preventive Perspective. View Abstract
Experiences and Perspectives on Stressors and Organizational Strategies to Bolster Resiliency During the COVID-19 Pandemic: A Qualitative Study of Health Care Workers at a Tertiary Medical Center. View Abstract
Disparities in Pediatric Mental and Behavioral Health Conditions. View Abstract
Daughters' Keeper - The Care and Treatment of Black Girls in America. View Abstract
From the Blood-Brain Barrier to Childhood Development: A Case of Acute-Onset Psychosis and Cognitive Impairment Attributed to Systemic Lupus Erythematosus in an Adolescent Female. View Abstract
Symptoms of Depression and Anxiety Among Black Medical Students: the Role of Peer Connectedness and Perceived Discrimination. View Abstract
This Is Us: a Case Examination on Black Men in Therapy. View Abstract
Health Data Disparities in Opioid-Involved Overdose Deaths From 1999 to 2018 in the United States. View Abstract
The relationship between alcohol and cannabis use with nonsuicidal self-injury among adolescent inpatients: Examining the 90 days prior to psychiatric hospitalization. View Abstract
Them and Me - The Care and Treatment of Black Boys in America. View Abstract
The Future Of Health Care, Today Prescription For The Future: The Twelve Transformational Practices Of Highly Effective Medical Organizations By Ezekiel J. Emanuel New York (NY) : PublicAffairs , 2017 272 pp., $27.00. View Abstract
Depression Remission Rates Among Older Black and White Adults: Analyses From the IRL-GREY Trial. View Abstract
Neuroendocrine phenotype alteration and growth suppression through apoptosis by MK-2206, an allosteric inhibitor of AKT, in carcinoid cell lines in vitro. View Abstract